Nancy Lin, MD

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Nancy Lin, MD sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).

4 total trials none currently recruiting 2 completed early-phase tilt upper quartile by trial count

Nancy Lin, MD: 4 sponsored US clinical trials, none currently recruiting.

Nancy Lin, MD sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 2 completed. 0 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Central Nervous System Metastases, with 1 trials.

Upper-quartile sponsor footprint

Nancy Lin, MD sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

4 total, page 1 of 1

ACTIVE NOT RECRUITING Phase 2

Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC

NCT03417544
TERMINATED Phase 2

ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases

NCT00496379
COMPLETED Phase 2

Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer

NCT00470704
COMPLETED Phase 1

Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer

NCT00470847

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 3

Therapeutic Areas

Central Nervous System Metastases 1
HER2-positive Metastatic Breast Cancer 1

How the Nancy Lin, MD early-phase archive is shaped

4 indexed studies, none listed as recruiting (0% open); 2 completed (50%).

Phase mix: 0 late (III/IV) vs 4 early (I/II) (early-phase heavy).

Top condition: Central Nervous System Metastases (1 trial), 1 other listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Nancy Lin, MD: archived-pipeline peers nationwide

Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Nancy Lin, MD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%20%40%60%80% Total trials Recruiting share Nancy Lin, MD4D pharma60 Degrees PharmaceuticalsA2 BiotherapeuticsAbdul Latif Jameel Poverty Action Lab10xBio22nd Century Group23andMe3-C Institute for Social Development
Nancy Lin, MD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Nancy Lin, MD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 4 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Nancy Lin, MD page

4 registered trials is a research-attention snapshot, not an endorsement of Nancy Lin, MD or any single study.

  • None of Nancy Lin, MD's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Central Nervous System Metastases is the condition Nancy Lin, MD studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Central Nervous System Metastases trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Nancy Lin, MD pipeline card: 4 registered trials from official public datasets.Report a data error.